Balance Sheet Boston Scientific Corporation
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
105.25 USD | +0.22% |
|
+2.82% | +17.83% |
02-07 | UBS Adjusts Boston Scientific Price Target to $130 From $105, Maintains Buy Rating | MT |
02-07 | The Employment Enigma | ![]() |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash And Equivalents | 217M | 1.73B | 1.92B | 928M | 865M | |||||
Trading Asset Securities, Total | - | - | - | - | - | |||||
Total Cash And Short Term Investments | 217M | 1.73B | 1.92B | 928M | 865M | |||||
Accounts Receivable, Total | 1.83B | 1.53B | 1.78B | 1.97B | 2.23B | |||||
Other Receivables | 105M | - | - | - | - | |||||
Total Receivables | 1.93B | 1.53B | 1.78B | 1.97B | 2.23B | |||||
Inventory | 1.58B | 1.35B | 1.61B | 1.87B | 2.48B | |||||
Prepaid Expenses | - | - | - | - | - | |||||
Deferred Tax Assets Current | - | - | - | - | - | |||||
Restricted Cash | 346M | 208M | 188M | 149M | 130M | |||||
Other Current Assets, Total | 624M | 1.87B | 816M | 846M | 807M | |||||
Total Current Assets | 4.7B | 6.69B | 6.32B | 5.76B | 6.51B | |||||
Gross Property Plant And Equipment | 5.5B | 5.77B | 5.96B | 6.11B | 6.78B | |||||
Accumulated Depreciation | -3.09B | -3.22B | -3.27B | -3.28B | -3.48B | |||||
Net Property Plant And Equipment | 2.42B | 2.54B | 2.69B | 2.83B | 3.3B | |||||
Long-term Investments | 458M | 918M | 412M | 407M | 413M | |||||
Goodwill | 10.18B | 9.95B | 11.99B | 12.92B | 14.39B | |||||
Other Intangibles, Total | 8.22B | 6.14B | 6.24B | 5.97B | 6.03B | |||||
Deferred Tax Assets Long-Term | 4.2B | 4.21B | 4.14B | 3.94B | 3.84B | |||||
Other Long-Term Assets, Total | 403M | 327M | 448M | 639M | 650M | |||||
Total Assets | 30.56B | 30.78B | 32.23B | 32.47B | 35.14B | |||||
Liabilities | ||||||||||
Accounts Payable, Total | 542M | 513M | 794M | 862M | 942M | |||||
Accrued Expenses, Total | 1.58B | 1.67B | 1.88B | 1.86B | 2.14B | |||||
Short-term Borrowings | 700M | - | - | - | - | |||||
Current Portion of Long-Term Debt | 716M | 13M | 261M | 20M | 531M | |||||
Current Portion of Leases | 67M | 70M | 71M | 61M | 76M | |||||
Current Income Taxes Payable | 265M | 158M | 209M | 232M | 220M | |||||
Unearned Revenue Current, Total | 144M | 138M | 208M | 220M | 266M | |||||
Deferred Tax Liability Current | - | - | - | - | - | |||||
Other Current Liabilities | 849M | 1.12B | 848M | 553M | 762M | |||||
Total Current Liabilities | 4.87B | 3.68B | 4.27B | 3.8B | 4.93B | |||||
Long-Term Debt | 8.59B | 9.12B | 8.8B | 8.91B | 8.57B | |||||
Long-Term Leases | 282M | 408M | 395M | 352M | 395M | |||||
Unearned Revenue Non Current | - | 257M | 276M | 289M | 311M | |||||
Deferred Tax Liability Non Current | 595M | 330M | 310M | 144M | 134M | |||||
Other Non Current Liabilities | 2.36B | 1.65B | 1.55B | 1.4B | 1.27B | |||||
Total Liabilities | 16.69B | 15.45B | 15.61B | 14.9B | 15.61B | |||||
Common Stock, Total | 16M | 17M | 17M | 17M | 17M | |||||
Additional Paid In Capital | 17.56B | 19.73B | 19.99B | 20.29B | 20.65B | |||||
Retained Earnings | -2.25B | -2.38B | -1.39B | -750M | 819M | |||||
Treasury Stock | -1.72B | -2.25B | -2.25B | -2.25B | -2.25B | |||||
Comprehensive Income and Other | 270M | 206M | 262M | 268M | 50M | |||||
Total Common Equity | 13.88B | 15.33B | 16.62B | 17.57B | 19.28B | |||||
Minority Interest | - | - | - | - | 248M | |||||
Total Equity | 13.88B | 15.33B | 16.62B | 17.57B | 19.53B | |||||
Total Liabilities And Equity | 30.56B | 30.78B | 32.23B | 32.47B | 35.14B | |||||
Supplemental Items | ||||||||||
ECS Total Shares Outstanding on Filing Date | 1.4B | 1.42B | 1.43B | 1.43B | 1.47B | |||||
ECS Total Common Shares Outstanding | 1.39B | 1.42B | 1.43B | 1.43B | 1.47B | |||||
Book Value / Share | 9.95 | 10.82 | 11.66 | 12.26 | 13.16 | |||||
Tangible Book Value | -4.52B | -760M | -1.6B | -1.32B | -1.14B | |||||
Tangible Book Value Per Share | -3.24 | -0.54 | -1.12 | -0.92 | -0.78 | |||||
Total Debt | 10.35B | 9.61B | 9.52B | 9.34B | 9.57B | |||||
Net Debt | 10.13B | 7.88B | 7.6B | 8.42B | 8.7B | |||||
Debt Equivalent of Unfunded Proj. Benefit Obligation | 156M | 176M | 166M | 106M | 117M | |||||
Debt Equivalent Oper. Leases | 640M | 736M | 720M | 728M | 768M | |||||
Minority Interest, Total (Incl. Fin. Div) | - | - | - | - | 248M | |||||
Equity Method Investments, Total | 263M | 319M | 259M | 188M | 219M | |||||
Account Code - Inventory Valuation | 5 | 5 | 5 | 5 | 5 | |||||
Inventories - Raw Materials, Total | 416M | 349M | 452M | 548M | 773M | |||||
Inventories - Work In Process, Total | 192M | 109M | 128M | 147M | 174M | |||||
Inventories - Finished Goods, Total | 971M | 893M | 1.03B | 1.17B | 1.54B | |||||
Land - (BS) | 117M | 104M | 109M | 137M | 140M | |||||
Buildings, Total | 1.2B | 1.29B | 1.34B | 1.7B | 1.84B | |||||
Machinery, Total | 3.41B | 3.47B | 3.48B | 3.3B | 3.5B | |||||
Full Time Employees | 36K | 38K | 41K | 45K | 48K | |||||
Accumulated Allowance for Doubtful Accounts (Supple) | 74M | 105M | 108M | 109M | 110M |